Showing results (231-240 of 6,200) with videos related to
Sort By:
Pageof 620
Cell Death & Disease|October 27, 2017
MiR-629 promotes human pancreatic cancer progression by targeting FOXO3Haijiao Yan, Qing Li, Jun Wu, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 30, 2017
The safety and efficacy of microwave ablation for the treatment of CRC pulmonary metastasesGui Cheng, Liangrong Shi, Weiguang Qiang, et al.Oncotarget|February 1, 2018
Expression of CCR6 in esophageal squamous cell carcinoma and its effects on epithelial-to-mesenchymal transitionJian Liu, Xiao Zheng, Haifeng Deng, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 20, 2017
Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian CancerYun Xu, Lujun Chen, Bin Xu, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 22, 2017
Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK TherapyJing Li, Lujun Chen, Yuqi Xiong, et al.Clinical and Experimental Medicine|August 6, 2025
The role and mechanism of ARID1A in immunotherapy of gastric cancerWenting He, Yue Chen, Xue Yao, et al.Pathology Oncology Research : POR|December 22, 2016
Interleukin-33 Expression does not Correlate with Survival of Gastric Cancer PatientsWenwei Hu, Xiaodong Li, Qing Li, et al.Cancer Immunology, Immunotherapy : CII|August 21, 2010
Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancerJingting Jiang, Yibei Zhu, Changping Wu, et al.Cancer Biology & Therapy|December 1, 2015
First-line treatment with hepatic arterial infusion plus capecitabine vs capecitabine alone for elderly patients with unresectable colorectal liver metastasesXiaodong Li, Liangrong Shi, Jun Wu, et al.Oncotarget|December 15, 2015
Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancerChangping Wu, Xin Jin, Jing Yang, et al.Pageof 620